Bilcare Current Share Price | Bilcare Stock Screener
BI
Healthcare Technology
Bilcare Current Stock Price Today
Live Share Price NSE
₹101.38
▲
9.21 (9.99%)
Live Share Price BSE
₹109.14
▲
5.19 (4.99%)
As of August 18, 2026, the live Bilcare share price (NSE: BI) is ₹101.38 on NSE and ₹109.14 on BSE, up 9.99% from the previous close, with shares trading between ₹92.17 and ₹101.38 in today's trading session, and a 52-week range of ₹56.18–₹101.38.
Browse BI complete financial statements to support your investment research.
Use the Bilcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Bilcare Market Cap
₹218.78 Cr.
BI P/E Ratio (TTM)
-33.07
Bilcare P/B Ratio
1.07
EPS (TTM)
₹0.73
Dividend Yield
-
Debt to Equity
1.98
BI 52 Week High
₹101.38
Bilcare 52 Week Low
₹56.18
Operating Margin
16.00%
Profit Margin
6.58%
BI Revenue (TTM)
₹228.00
EBITDA
₹37.00
Net Income
₹15.00
Total Assets
₹843.00
Total Equity
₹197.00
Bilcare Current Share Price Chart
Track the current Bilcare share price and stock price with an interactive chart. Analyse BI price trends, trading volume, historical performance, and volatility across different timeframes — the complete Bilcare stock quote in one place.
Bilcare Company Profile - Fundamental Screener
Screen Bilcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BI shares.
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
ISIN
INE986A01012
Bilcare Balance Sheet Screener
Screen BI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 843 | 1,417 | 1,568 | 1,593 | 1,127 | 1,064 | 1,112 | 3,159 | 3,479 | 3,507 |
| Current Assets | 353 | 343 | 411 | 343 | 421 | 337 | 365 | 882 | 933 | 788 |
| Fixed Assets | 441 | 949 | 1,038 | 1,046 | 465 | 494 | 534 | 2,006 | 2,180 | 2,403 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 477 | 488 | 572 | 551 | 563 | 586 | 624 | 1,096 | 1,037 | 2,085 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 197 | 590 | 646 | 704 | 161 | 164 | 176 | -6 | 463 | 676 |
| Share Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves & Surplus | 173 | 446 | 474 | 507 | 52 | 63 | 85 | -93 | 376 | 590 |
Bilcare Income Statement Screener - Profit & Revenue Analysis
Screen Bilcare income statement and profit fundamentals.
Analyze BI quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Bilcare share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 228 | 202 | 187 | 183 | 192 | 215 | 202 | 206 | 198 | 198 | 209 | 179 | 200 | 186 | 465 |
| Expenses | 191 | 173 | 170 | 175 | 175 | 186 | 197 | 204 | 175 | 175 | 208 | 158 | 183 | 170 | 219 |
| EBITDA | 37 | 29 | 16 | 8 | 17 | 29 | 4 | 2 | 23 | 23 | 1 | 21 | 17 | 16 | 246 |
| Operating Profit % | 16.00% | 8.00% | 6.00% | 2.00% | 6.00% | 4.00% | 0.00% | -1.00% | 10.00% | 10.00% | -4.00% | 10.00% | 4.00% | 7.00% | 6.00% |
| Depreciation | 4 | 5 | 5 | 12 | 12 | 5 | 12 | 11 | 12 | 12 | 13 | 11 | 11 | 11 | 9 |
| Interest | 18 | 18 | 17 | 19 | 19 | 19 | 20 | 24 | 21 | 21 | 23 | 21 | 20 | 19 | 11 |
| Profit Before Tax | 15 | 7 | -6 | -24 | -13 | 6 | -27 | -33 | -10 | -10 | -35 | -10 | -13 | -13 | 225 |
| Tax | 0 | -1 | 0 | 0 | -3 | -7 | -11 | -3 | 5 | 5 | -16 | 3 | -1 | 0 | 147 |
| Net Profit | 15 | 8 | -6 | -23 | -10 | 12 | -16 | -30 | -15 | -15 | -20 | -14 | -12 | -13 | 78 |
| EPS | 5.39 | 5.68 | 0.41 | -5.25 | -1.61 | 7.47 | -3.05 | -6.81 | -2.71 | -2.71 | -4.63 | -2.91 | -3.22 | -3.36 | 19.63 |
Bilcare Cash Flow Screener - Liquidity Fundamentals
Screen BI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 63 | -7 | 41 | 72 | 256 | 206 | 99 | 300 | 177 | -315 |
| Investing Activities | -106 | 36 | -4 | 2 | 1,309 | -104 | -203 | -129 | -358 | 247 |
| Financing Activities | 36 | -19 | -55 | -83 | -1,600 | -103 | 91 | -155 | 149 | 119 |
| Net Cash Flow | -8 | 10 | -18 | -9 | -35 | -1 | -13 | 16 | -32 | 50 |
Bilcare Shareholding Pattern Screener
See Bilcare shareholding pattern with promoter, FII, and DII holdings.
Check Bilcare promoter holding and ownership changes for BI on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% |
| FII Holding | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 45.18% | 45.32% | 44.68% | 44.96% | 45.40% | 45.45% | 45.48% | 45.57% |
| Other Holding | 24.76% | 24.62% | 25.26% | 24.99% | 24.54% | 24.49% | 24.46% | 24.37% |
| Shareholder Count | 15,824 | 15,777 | 17,586 | 17,047 | 16,513 | 16,068 | 19,116 | 18,783 |
Bilcare Share Dividend Screener - Share Yield Analysis
Check Bilcare dividend history with payout and yield data.
View Bilcare dividend details including ex-dates and amounts for BI stock.
Bilcare Stock Index Membership
See which indices include Bilcare stock.
Check BI index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Bilcare Market Events Screener - Corporate Actions
Get Bilcare corporate actions including splits, bonuses, and buybacks.
Check Bilcare stock events that may affect BI share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-26 | 2026-09-26 | Annual General Meeting | NA | 1.79% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 5.28% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | -1.29% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 2.30% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -5.12% |
| 2025-09-24 | 2025-09-24 | Annual General Meeting | NA | 31.15% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -1.45% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -0.20% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -13.94% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -5.03% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | -7.47% |
Bilcare Competitors Screener - Peer Comparison
Screen BI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 15,446 | 70.24 | 3,809 | 2.56% | 317 | 34.74 |
| Indegene | 13,936 | 34.68 | 3,583 | 21.58% | 401 | 53.06 |
| Suven Life Sciences | 10,047 | -28.99 | 21 | 19.32% | -276 | 49.69 |
| Vimta Labs | 2,812 | 35.09 | 322 | 0.22% | 41 | 50.83 |
| TAKE | 261 | 19.45 | 54 | 431.27% | 11 | 47.08 |
| Bilcare | 219 | -33.07 | 734 | -9.05% | -21 | 57.83 |
| Jeevan Scientific Technology | 164 | 31.95 | 62 | 29.56% | 2 | 63.29 |
| Adeshwar Meditex | 24 | 33.09 | 56 | -33.21% | 1 | 50.09 |
| Vanta Bioscience | 15 | 137.20 | 2 | -13.33% | 0 | 14.70 |
Bilcare Company Announcements - News Screener
Screen BI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-11 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-09-11 | Reg. 34 (1) Annual Report. | - |
| 2026-09-11 | Annual Report - 2025-26 | - |
| 2026-08-22 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Voluntary Winding Up Of Wholly Owned Subsidiary | - |
| 2026-08-13 | Appointment of Company Secretary and Compliance Officer | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-13 | Standalone & Consolidated Unaudited Financial Results For The Quarter Ended On 30 June 2026 Along With Limited Review Report Issued By Statutory Auditors Of The Company | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-08-07 | Board Meeting Intimation for Considering Standalone & Consolidated Unaudited Financial Results For The Quarter Ended On 30 June 2026 | - |
| 2026-07-24 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-23 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-22 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-06-12 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-06-04 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |